CEACAM8 and B-cell non-Hodgkin lymphoma: Worthy of note, the correlation that we reported between the percentage of circulating CD66b+CD33dimHLA-DR− G-MDSCs at the time of diagnosis and disease prognostic scores and outcome, suggests that the latter cells may be a suitable prognostic marker in HL and B-cell NHL.